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countries where rates have reached 30-40%. In addition, this patho- 
gen has low intrinsic susceptibility to macrolides. Additionally, the 
vast majority of Moraxella catarrhalis strains now produce beta- 
lactamase-90-100% in many regions-making many beta-lactams 
of limited value in empirical treatment of infections that may be 
caused by H .  iq'henzae or M .  catarrhalis. 
These findings emphasize the need for the use of effective 
antibiotics to overcome the problem of resistance, the continued 
epidemiologic monitoring of antimicrobial resistance, both globally 
and locally, and the importance of reassessing current antimicrobial 
practice. 
F l  Predicting clinical success in community 
respiratory tract infections 
F. Goldstein. Laboratoire de Microbiologie Medicale Fundation, Paris, 
France 
Increasing antibiotic resistance across many parts of the world means 
that rational and evidence-based choices for antibiotic treatments are 
becoming increasingly important if the consequences of resistance are 
to be minimized. Prescribers may find that they need to reassess their 
current antibiotic choices based on criteria which can predict 
bacteriologic and clinical success. Animal models and clinical studies 
have shown that pharmacokinetic and pharmacodynamic (PD) 
parameters are the key to predicting optimal clinical efficacy. 
For beta-lactams and some macrolides, the time for which the 
serum concentration exceeds the MIC is an accurate determinant of 
efficacy. Bacteriologic success is achieved with a time above MIC of 
40% of the dosage interval for penicillins, and 50% for cephalosporins 
and some macrolides. For azithrornycin and quinolones, AUC/MIC 
ratio is the key PD parameter. An AUC/MIC ratio of 25 is generally 
thought to predict good bacteriologic efficacy for non-serious 
infections in ininiunocompetent patients. The utility of PD para- 
meters for predicting bacteriologic and clinical outcomes has been 
correlated with outcomes in otitis media and sinusitis, and confirmed 
in an otitis media clinical model. Using PD parameters, MIC break- 
points predictive of clinical outcome can be defined. These break- 
points, based on the serum concentration of antibiotic present for a 
given percentage of the dosing interval and used in conjunction with 
MIC data from local surveillance studies, predict the susceptibility of 
clinical isolates to individual antibiotics. Using these criteria, 
amoxycillin/clavulanate is identified as the antibiotic of choice for 
empirical treatment of respiratory tract infections, with the exception 
of infections due to atypical microorganisms. 
ml SB-265805 (SB), a potent new quinolone 
A.R. MacGowan. BCARE, Southmead Hospital, Bristol, UK 
SB (LB 20304a) is a new quinolone which has an oxime-derivatized 
(aminomethyl) pyrrolidine substituent at C7 conferring strong 
Gram-positive and -negative activity plus favorable pharniaco- 
kinetics. MIGo values are low against a range of respiratory patho- 
gens when compared to other quinolones. 
SB MICm are: <=0.06 mg/L for group A streptococci, MSSA, 
E. coli, Enterobacter aerogenes and Salmonella; 0.12-0.25 mg/L for 
Enterobacter cloacae, Klebsiella spp. and Proteus vulgaris; /=0.5 mg/L for 
Proteus mirabilis, Morganella morgani, Serratia, Citrobacter, enterococci 
and MRSA. SB is bactericidal against Streptococcus pneumoniae (SP), 
Haemophilus injnenzae (HI), Moraxella cutarrhalis , Staphylococcus aureus, 
E .  coli and Pseudomonas aeruginosa and has a PAE of 2 h with 
Staphylococcus aureus and 19 h with E. coli. Compared to other new 
quinolones such as grepafloxacin, levofloxacin or trovafloxacin, SB is 
more active against quinolone-resistant HI or SP strains. A standard 
20 mg/kg dose in rats resulted in a 1.5-fold greater AUC (IV dose), 
a 2-fold greater C,,, and a similar t 112 to ciprofloxacin. SB is likely 
to have clinically useful activity against pathogens causing RTI, 
including those resistant to present quinolones. 
ml Clinical outcomes in a resistance environment 
U. Schaad. UfLiversiry o/Basel, Department o f  Pediatrics, Basel, 
Switzerland 
Increasing antibiotic resistance has a negative impact on the treatment 
of respiratory tract infection (RTI), but the true extent of this impact 
has remained largely unquantified. Recent studies in acute otitis 
media have established the double tap methodology (tympanocentesis 
on day 1 and day 4-5 of treatment) as an effective clinical model, 
allowing investigation of the link between antibiotic resistance and 
antibiotic efficacy as determined by successful bacterial eradication 
and clinical outcome. Double tap studies show a good correlation 
between increasing MICs and increasing bacteriological failure rates, 
as well as showing correlation between bacteriological activity and 
clinical efficacy. Bacteriological eradication on day 4-5 gives a 97% 
chance of clinical success. Failure to eradicate pathogens results in 
clinical failure in around 40% of patients. Double tap studies also 
show that successful bacteriological eradication is linked to a greater 
improvement in clinical outcome, as shown by reduction of signs and 
symptoms. This clinical model confirms the need to use potent 
antibacterial agents that are able to eradicate the pathogen from the 
site of infection. Beta-lactams such as amoxycillin +clavulanate and 
cefiiroxime currently remain the first choice for acute otitis media 
based on good bacterial eradication of Streptococcus Pneumaniae 
(including intermediate penicillin-resistant strains) and Haemophilus 
inzuenzae (including beta-lactamase-producing strains). 
Infections and cytokines 
m] IL-12 and TNF in infections 
C.A. Dinarello. University of Colorado, Infectious Diseases, Denver, 
co, USA 
The inflammatory cytokines IL-1 and TNF have the same spectrum 
of properties as bacterial products. When administered to humans, 
these cytokines are as toxic as bacterial products. Attention has now 
focused on the concept that the biological properties of IL-1 and 
TNF should be blocked. Blocking IL-1 or TNF has been highly 
successful in patients with rheumatoid arthritis, inflammatory bowel 
disease or graft versus host disease. However, despite a large body of 
animal data, anti-cytokine therapy for sepsis has been disappointing. 
Over 13 000 patients with septic shock have entered trials with TNF- 
neutralizing antibodies, soluble TNF receptors and IL-1 receptor 
antagonist in double-blind, placebo-controlled trials. Although there 
has been a highly consistent small (2-3% increase in 28-day survival 
with anti-cytokine therapy, the effect has not been statistically 
significant. Certain subgroups, such as patients with disseminated 
intravascular coagulation, show remarkable improvement with anti- 
TNF therapy. Meta-analysis of anti-cytokine therapy in sepsis 
concluded that the benefit was small because the sample size of each 
trial is small. Also, no harm appears to be associated with anti- 
cytokine therapy. A combination of blocking TNF and IL-1 may 
offer the patient with Gram-negative septic shock the greatest chance 
of rescue. Another approach is to treat patients with immuno- 
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stimulants to restore the immunosuppression that accompanies sepsis. 
Unfortunately, it remains difficult to identify those patients who 
benefit from anti-cytokine therapies in septic shock and those who 
do not. For example, a recent trial of NMMA (blacking the synthesis 
of nitric oxide, NO)  resulted in a greater mortality than with placebo. 
Thus, there are patients who should not receive anti-cytokine 
therapy, as this also reduces NO synthesis. 
Molecular methods for the diagnosis of 
infectious diseases 
ml Direct visualization of microorganisms by 
fluorescence in situ hybridization 
A. Moter. ~iniversit&tsklinikrm Charitl, Mikrobiologie rind Hy‘qiene, 
Berlin, Germany 
The  ultimate goal oE diagnostic microbiology is the rapid and 
accurate identification of bacteria in their natural environments. 
Fluorescence in situ hybridization (FISH) allows molecular detection 
of niicroorganisnis on a single-cell level. It therefore provides 
additional plausibility by involving morphologic criteria. Further- 
more, the analysis of surrounding cells and tissues becomes possible. 
The  most commonly used target for probes used in microbiology is 
ribosoiiial 16s RNA.  Fluorescence-labeled D N A  fragments or 
oligonucleotxdes applied as a probe to tissue and smear preparations 
enable the visualization of bacteria by a single hybridization step 
within a couple of hours. Probes have been successfully used for the . 
identification of hitherto uncultured microorganisms. Being faster 
than cultivation methods and cheaper than PCR-based methods, 
FISH has the potential to become a useful tool in environmental, 
medical and veterinary medicine. However, a number of difficulties 
and pitfalls have to be considered. Experience and careful controls 
arc crucial for the interpretation of results and its future application 
in medical dia&mosis. 
w] High-density oligonucleotide arrays 
A. Troesch. Mnrcy-I’Etoilt., Pork, France 
The Genechip technology, developed by Affyrnetrix, is a promising 
new method for assessing genetic diversity on a larger scale. This 
technology, which relies upon hybridization of the nucleic acid target 
with tens to hundreds of thousands of oligonucleotides synthesized 
on  a ininiaturized glass support, is expected to have extensive appli- 
cations in infectious disease diagnostics. We have investigated this 
probe array strategy both for bacteriology and virology testing and 
have designed specific probe arrays for: (1) identification of niyco- 
bacteria species and detection of mutations associated with antibiotic 
resistance in Mycohacteriimz tuberculosis; and (2)  monitoring of the 
emergence of antiviral drug resistance in HIV. Hybridization on the 
arrays, scanning and data analysis can be performed in 1 h. The  
mycobacterium probe array has been validated on  an extensive panel 
of Mycobacterium strains and rifampin-resistant Mycobacterium 
ruberculosis isolates. The  feasibility of drug resistance detection in HIV 
has been demonstrated for various mutations located on the protease 
and reverse transcriptase genes. Overall, this new technology opens 
new perspectives in terms of patient management for infectious 
diseases, by allowing a number of genetic tests to be run sirnul- 
taneonsly The principle of the technology, validation results and 
potential diagnostic applications of probe arrays will be discussed. 
wl Identification of uncultured bacteria 
U. Gobe.1. bistiturJur Milerohioloyie und Hyqietie, Berliri, C;(WIOJI), 
Currently we are witnessing a transition from culture-based detection 
to growth-itidrpendent niolecular identification of i i i icr~~~~r~i i i is i i is .  
Special protocols have been developed to enrich and analyze q 3 t ~ i n l  
genes or transcripts. The most widespread technique used in bactcrio- 
loby is the comparative analysis of ribosomal rKNA gciic\ oi- 
fragments thereof. The architecture and the ubiquitous nature of this 
molecule allow rapid and unequivocal identification of not ciiily 
cultured but also uncultured bacteria, including iiovel bdcteri‘i in 
coiiiplex environmental habitats as well ~s novel emerging pathogen?. 
Advantages and pitfalls of this technique are discuwd. 
wl Methods for ultra-sensitive detection and 
quantitation of genes and mRNA 
€? Williams. Antibody and Bionssay T r c / i ~ i ~ / o < ~ ) :  7?c/iriolq~y (;rricwtcc/i 
luc , ,  SOJ~ Frafzcisco, CA, USA 
Several approaches have been tdken for ultra-sensitive detection of 
specific nucleic acid sequences: (1) signal amplification mrthod\ and 
( 2 )  target amplification methods. Most traditional nuclcic acid 
detection methods rely on  isotopic probes in order to detcct 
sequences of interest in a biological sample. Recently, a iiiultitudc o t  
non-isotopic methods have been ciiiployed, relying o n  ei~zyiiiatic 
amplification of a signal. One such appi-oach, branched DNA (b- 
DNA; Chiron Diagnostics), provides a very sensitive and quantit.itive 
detection method. A description of this technique and its ,ipplicntion 
to quantitative inKNA studies will be dejcribed. The advcnt of  the 
polyinerase chain reaction (PCR), a tarset miplificatiwi nicthod, hAs 
also permitted very sensitive detection of nucleic acid tcqueiicc\. 
Attempts to develop quantitative applications of I’CR u c  hindcrcd 
by several obstacles inherent in the methodoloby The development 
of ‘real-time quantitative PCR’ has largely overconic many of the 
obstacley. A description of the ‘real-tinic quantitative l’Cl<’ tiiethod 
and applications will be presentcd. Finally, tlic topic\ of saiiplc 
preparation, assay design and interpretation of quantitative ineawrr- 
ments of nucleic acid sequences will addressed 
F l  Spoligotyping in the epidemiology of 
tuberculosis 
J. van Embden, T. van Gorkoni, K. Kreiiier, L. Schoul\. Labiiruriiry 
j r  Irfertious Disease Research, Nntiorlal Itistitute of Priblic Hedlrli mi i f  
the Eiwiroiirwut, Bilthuven, The Netherlarids 
Mycohaclerium tuberculosis complex strain5 contain an unusual genetic 
DNA locus carrying multiple direct repeats (DRs) of 36 base pair\, 
which are spaced by non-repetitive DNA spacers of similar s~ze. The 
sequence of the I I R  is specific for 12.1. rubertulosis complex bacteria 
and therefore the D R  locus is an excelleiit multicopy t q e t  for I ’ C X  
detection of pathogenic mycobacteria. l h r  to the strain-depcndeiit 
absence or  presence of spacers we have developed .I rapid niethod 
(spacer ohgotyping or spoligotyping) to differentiate clinical ~tolates 
for the epidemiology of tuberculosis. Spoligotpying can be carried 
out directly on  clinical material and on stained microscopic s l ~ d e ~ ,  
thus allowing siniultaiirous detection and strain typmg of M. 
tirherculosis complex bacteria in clinical saniples. In an nttennpt to 
increase the level of strain differentiation by spoligotyping and to get 
insight into the nature of the I3R-associated DNA polymorphi\ni, 
we have sequenced 13R loci in various clinical isolate\. More than 60 
different spacers have been identified and .Vl. h i s ,  M. tnirroti .md .\I 
